Embecta Corp. (EMBC) vs Ocugen, Inc. (OCGN)
A side-by-side comparison of Embecta Corp. and Ocugen, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EMBC
Embecta Corp.
$6.02HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
OCGN
Ocugen, Inc.
$1.06HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
Total return — EMBC vs OCGN
growth of $100 · dividends reinvested · last 5yEMBC -85.5% (-32.1%/yr)OCGN -72.0% (-22.5%/yr)OCGN compounded faster over this window
EMBC OCGN
EMBC vs OCGN: by the numbers
- •OCGN is the larger company ($359M vs $357M market cap).
- •EMBC is profitable (8.59% net margin) while OCGN runs a net loss (-1786.27%).
- •EMBC pays a dividend (5.44% yield), while OCGN has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | EMBC | OCGN |
|---|---|---|
| P/E ratio | 4.07 | N/A |
| Forward P/E | 3.42 | N/A |
| P/S ratio | 0.35 | 78.48 |
| EV / EBITDA | 5.39 | N/A |
| FCF yield | 46.05% | N/A |
Profitability
| Metric | EMBC | OCGN |
|---|---|---|
| Gross margin | 59.89% | 45.86% |
| Operating margin | 24.85% | -1425.70% |
| Net margin | 8.59% | -1786.27% |
| ROIC | 17.99% | -93.74% |
Dividends
| Metric | EMBC | OCGN |
|---|---|---|
| Dividend yield | 5.44% | N/A |
| Payout ratio | 21.62% | N/A |
Growth (annualized)
| Metric | EMBC | OCGN |
|---|---|---|
| Revenue CAGR (5Y) | -0.09% | N/A |
| EPS CAGR (5Y) | -26.22% | N/A |
| FCF CAGR (5Y) | -16.77% | N/A |
| Total return CAGR (5Y) | N/A | -31.57% |
Frequently asked
- Does EMBC or OCGN pay a bigger dividend?
- EMBC pays a dividend (5.44% yield), while OCGN has no payments in the available dividend history.
- Is EMBC or OCGN more profitable?
- EMBC runs the higher net margin — EMBC at 8.59% versus OCGN at -1786.27%.
Go deeper
Dig into the metrics
Embecta P/E ratioEmbecta dividend yieldEmbecta ROEOcugen ROEEmbecta operating marginOcugen operating marginEmbecta revenue growthOcugen revenue growthEmbecta free cash flowOcugen free cash flow
Embecta & Ocugen appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.